BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27714592)

  • 1. Characteristics of cefazolin inoculum effect-positive methicillin-susceptible staphylococcus aureus infection in a multicentre bacteraemia cohort.
    Song KH; Jung SI; Lee S; Park S; Kiem SM; Lee SH; Kwak YG; Kim YK; Jang HC; Kim YS; Kim HI; Kim CJ; Park KH; Kim NJ; Oh MD; Kim HB;
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):285-294. PubMed ID: 27714592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of cefazolin inoculum effect and β-lactamase type on methicillin-susceptible Staphylococcus aureus bacteremia.
    Lee S; Kwon KT; Kim HI; Chang HH; Lee JM; Choe PG; Park WB; Kim NJ; Oh MD; Song DY; Kim SW
    Microb Drug Resist; 2014 Dec; 20(6):568-74. PubMed ID: 25000230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of blaZ gene types and the cefazolin inoculum effect among methicillin-susceptible Staphylococcus aureus blood isolates and their association with multilocus sequence types and clinical outcome.
    Chong YP; Park SJ; Kim ES; Bang KM; Kim MN; Kim SH; Lee SO; Choi SH; Jeong JY; Woo JH; Kim YS
    Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):349-55. PubMed ID: 25213722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus blood isolates: their association with dysfunctional accessory gene regulator (agr).
    Wi YM; Park YK; Moon C; Ryu SY; Lee H; Ki HK; Cheong HS; Son JS; Lee JS; Kwon KT; Kim JM; Ha YE; Kang CI; Ko KS; Chung DR; Peck KR; Song JH
    Diagn Microbiol Infect Dis; 2015 Nov; 83(3):286-91. PubMed ID: 26277619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inoculum effect of high concentrations of methicillin-susceptible Staphylococcus aureus on the efficacy of cefazolin and other beta-lactams.
    Saeki M; Shinagawa M; Yakuwa Y; Nirasawa S; Sato Y; Yanagihara N; Takahashi S
    J Infect Chemother; 2018 Mar; 24(3):212-215. PubMed ID: 29198902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of a Cefazolin Inoculum Effect Associated with
    Wang SK; Gilchrist A; Loukitcheva A; Plotkin BJ; Sigar IM; Gross AE; O'Donnell JN; Pettit N; Buros A; O'Driscoll T; Rhodes NJ; Bethel C; Segreti J; Charnot-Katsikas A; Singh K; Scheetz MH
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29891607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus.
    Livorsi DJ; Crispell E; Satola SW; Burd EM; Jerris R; Wang YF; Farley MM
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4474-7. PubMed ID: 22585225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefazolin high-inoculum effect in methicillin-susceptible Staphylococcus aureus from South American hospitals.
    Rincón S; Reyes J; Carvajal LP; Rojas N; Cortés F; Panesso D; Guzmán M; Zurita J; Adachi JA; Murray BE; Nannini EC; Arias CA
    J Antimicrob Chemother; 2013 Dec; 68(12):2773-8. PubMed ID: 23794599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inoculum effect with cefazolin among clinical isolates of methicillin-susceptible Staphylococcus aureus: frequency and possible cause of cefazolin treatment failure.
    Nannini EC; Stryjewski ME; Singh KV; Bourgogne A; Rude TH; Corey GR; Fowler VG; Murray BE
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3437-41. PubMed ID: 19487449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative outcomes of cefazolin versus nafcillin for methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective multicentre cohort study in Korea.
    Lee S; Song KH; Jung SI; Park WB; Lee SH; Kim YS; Kwak YG; Kim YK; Kiem SM; Kim HI; Kim ES; Park KH; Kim NJ; Jang HC; Kim HB;
    Clin Microbiol Infect; 2018 Feb; 24(2):152-158. PubMed ID: 28694202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Insights into the Classification of Staphylococcal β-Lactamases in Relation to the Cefazolin Inoculum Effect.
    Carvajal LP; Rincon S; Echeverri AM; Porras J; Rios R; Ordoñez KM; Seas C; Gomez-Villegas SI; Diaz L; Arias CA; Reyes J
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cefazolin Inoculum Effect and the Presence of type A
    Lee SO; Lee S; Park S; Lee JE; Lee SH
    Infect Chemother; 2019 Dec; 51(4):376-385. PubMed ID: 31898425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Characterization of the Cefazolin Inoculum Effect in North American Methicillin-Susceptible Staphylococcus aureus Isolates.
    Dingle TC; Gamage D; Gomez-Villegas S; Hanson BM; Reyes J; Abbott A; Burnham CD; Dien Bard J; Fritz S; Miller WR; Westblade LF; Zimmer B; Arias CA; Butler-Wu S;
    J Clin Microbiol; 2022 Jul; 60(7):e0249521. PubMed ID: 35578988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A large retrospective cohort study of cefazolin compared with flucloxacillin for methicillin-susceptible Staphylococcus aureus bacteraemia.
    Davis JS; Turnidge J; Tong S
    Int J Antimicrob Agents; 2018 Aug; 52(2):297-300. PubMed ID: 29499317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Test for the Rapid Detection of the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.
    Rincon S; Carvajal LP; Gomez-Villegas SI; Echeverri AM; Rios R; Dinh A; Pedroza C; Ordoñez KM; Nannini E; Sun Z; Fowler VG; Murray BE; Miller WR; Palzkill T; Diaz L; Arias CA; Reyes J
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33536292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inoculum effect of methicillin-susceptible Staphylococcus aureus against broad-spectrum beta-lactam antibiotics.
    Song KH; Jung SI; Lee S; Park S; Kim ES; Park KH; Park WB; Choe PG; Kim YK; Kwak YG; Kim YS; Jang HC; Kiem S; Kim HI; Kim HB;
    Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):67-74. PubMed ID: 30269181
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Mossman AK; Svishchuk J; Waddell BJM; Izydorczyk CS; Buckley PT; Hilliard JJ; Al-Ghalith G; Zheng L; Lynch AS; Mody CH; Lisboa LF; Gregson DB; Parkins MD
    Ann Am Thorac Soc; 2022 Aug; 19(8):1285-1293. PubMed ID: 35213810
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiology and impact of methicillin-sensitive
    Svishchuk J; Ebbert K; Waddell B; Izydorczyk C; Acosta N; Somayaji R; Rabin HR; Bjornson CL; Lisboa L; Gregson DB; Conly JM; Surette MG; Parkins MD
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0013623. PubMed ID: 37966229
    [No Abstract]   [Full Text] [Related]  

  • 19. Association between Type A blaZ Gene Polymorphism and Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus.
    Lee SH; Park WB; Lee S; Park S; Kim SW; Lee JM; Chang HH; Kwon KT; Choe PG; Kim NJ; Kim HB; Oh MD
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6928-6932. PubMed ID: 27572417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continued in vitro cefazolin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Gern BH; Greninger AL; Weissman SJ; Stapp JR; Tao Y; Qin X
    Ann Clin Microbiol Antimicrob; 2018 Feb; 17(1):5. PubMed ID: 29463249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.